CD19 Receptor Interactions [MoA]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CD19 Receptor Interactions [MoA] includes 2 drugs with a combined 12,828 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
12,828
Combined Reports
All CD19 Receptor Interactions [MoA] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| AXICABTAGENE CILOLEUCEL | YESCARTA | 8,599 | 2,204 | 3,131 | 25.6% |
| TISAGENLECLEUCEL | KYMRIAH | 4,229 | 1,232 | 1,256 | 29.1% |
Common Side Effects in CD19 Receptor Interactions [MoA] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Cytokine release syndrome | 5,800 | 1,223 |
| Immune effector cell-associated neurotoxicity syndrome | 2,237 | 529 |
| Pyrexia | 1,889 | 436 |
| Neurotoxicity | 1,738 | 385 |
| Death | 1,038 | 1,038 |
| Disease progression | 925 | 414 |
| Hypotension | 823 | 242 |
| Malignant neoplasm progression | 616 | 414 |
| Diffuse large b-cell lymphoma | 591 | 386 |
| Platelet count decreased | 564 | 209 |